Telomerase enzyme research may help delay ageing and age-related diseases
Live Forever Club - 08-Dec-2024BioViva focuses on translating this research into therapies
Bioviva Science
Gene therapy innovation leaders developing platforms to treat severe genetic disorders and cellular aging
BioViva USA Inc is dedicated to improving healthy human longevity through gene therapy.
BIOVIVA'S patent pending technology will revolutionize gene therapy delivery. Our bioinformatics platform and the BioKeeper™ Vault will contribute to health predictions and recommendations, precision medicine, and the discovery of novel biomarkers. Helping us create even better therapies for you in the future!
Look for the first, easy to use, data base for disease specific information coming soon. BioViva will soon be welcoming the CodeKeeper™! A powerful tool to put open source genetics into your hands.
Visit website: https://bioviva-science.com/
Details last updated 04-Feb-2019
Bioviva Science is also referenced in the following:
Interview with BioViva founder Liz Parrish
Liz Parrish discusses the latest advancements in human gene therapy
Interview with Dr Andrews of Sierra Sciences
Dr. Andrews of Sierra Sciences discusses aging, telomeres, and treatment hurdles
Interview with Liz Parrish and Bill Andrews
Liz Parrish and Bill Andrews share practical tips for achieving biological rejuvenation
People at Bioviva Science
Bioviva Science News
Lifespan of middle-aged mice increased by a third with telomerase gene therapy
CISION PR Newswire - 19-May-2022Treatment used proprietary CMV vector which is able to deliver multiple genes into the nucleus
Longevity.Technology looks at 12 key companies running age-related disease clinical trials in 2021
Longevity Technology - 25-Feb-2022Approaches include senotherapeutics, stem cells and mitochondria. Eye disease is a common first target.
New study where biological age reduces as chronological age increases
Bioviva Science - 18-Nov-2021Evident reversal of Dementia symptoms sustained cognitive improvement
BioViva tests experimental telomerase gene-therapy in 6 Alzheimer's patients
Biospace - 03-May-2021Launched home test to track biological age; outcomes of unlicensed gene-therapy are yet to report
Master Investor Magazine focuses on longevity in its Autumn edition
Master Investor - 01-Nov-2019Interesting articles and some useful investment opportunities
Ageing is a Disease. Gene Therapy Could be the Cure
WIRED - 20-Apr-2017Most age related diseases are a symptom of cellular malfunction. Gene therapy allows us to repla...
Target Genes for Slowing Aging
Fight Aging! - 06-Jun-201675 potential targets for gene therapy in the near future. Rapid advances in genetic editing tech...
BioViva Moving Ahead With Human Gene Therapy for Telomerase Activation
Fight Aging! - 02-Apr-2015First company to treat a person with gene therapy to reverse biological aging. Patient to be mon...
Existing Longevity Therapies that are Technically Feasible, but Difficult and Expensive to Obtain
Fight Aging! - 28-Dec-2014Gene therapies Stem cell therapies Enhancing native stem cell activities Thymus restoration I...
Topics mentioned on this page:
Gene Therapy
